Gilead: ensure access to remdesivir, a promising treatment for coronavirus (Open letter)
Home Slider
Gilead: ensure access to remdesivir, a promising treatment for coronavirus (Open letter)
31/03/2020 by in Home Slider
Open letter to the World Health Organization (WHO) and its Member States
Home Slider
Open letter to the World Health Organization (WHO) and its Member States
27/03/2020 by in Home Slider
Pharmaceutical Policy in Times of Health Emergency
Home Slider
Pharmaceutical Policy in Times of Health Emergency
27/03/2020 by in Home Slider
Open letter to the EU: the treatments developed for COVID19 with public money must be accessible
Home Slider
Open letter to the EU: the treatments developed for COVID19 with public money must be accessible
26/03/2020 by in Home Slider
What are we learning from the coronavirus crisis?
Home Slider
What are we learning from the coronavirus crisis?
19/03/2020 by in Home Slider
‘Transparency has an impact on the population’s health’
Home Slider
‘Transparency has an impact on the population’s health’
17/02/2020 by in Home Slider
A great victory for transparency
Home Slider
A great victory for transparency
30/01/2020 by in Home Slider
We review 2019… and wish you happy 2020!
Home Slider
We review 2019… and wish you happy 2020!
30/12/2019 by in Home Slider
We won a Desalambre award!
Home Slider
We won a Desalambre award!
19/12/2019 by in Home Slider
“The opacity in the medicine market is antidemocraticâ€
Home Slider
“The opacity in the medicine market is antidemocraticâ€
11/12/2019 by in Home Slider